The national government continues to promote the high-quality development of the “medicine and food homology” (dual-purpose medicinal and edible) industry, encouraging the integration of traditional health-promoting ingredients with modern bioprocessing technologies to create high-value-added products. Kudzu root (*Pueraria lobata*), a classic dual-purpose ingredient, enjoys strong market recognition; however, the traditional kudzu powder market is plagued by severe product homogenization, limited absorption efficiency, and cutthroat competition. In contrast, kudzu root small-molecule peptides—produced via targeted enzymatic hydrolysis—represent an upgraded, highly differentiated product category. They serve as an ideal “blue ocean” offering for health-focused retail channels, capable of generating high profit margins, with a market that continues to see rapid growth.
Many professionals in the health industry have observed that conventional kudzu products suffer from transparent pricing and razor-thin profit margins, making customer conversion difficult and repeat purchases rare. Kudzu peptides, however, utilize enzymatic hydrolysis to break down large-molecule kudzu components into small-molecule peptides, which offer superior absorption and bioavailability. Targeting specific groups—such as those with frequent social/business engagements, irregular sleep schedules, or a keen interest in wellness—these peptides stand apart from standard kudzu powder, making it easier to establish product value and escape the trap of price-based competition. Yet, truly qualified manufacturers—those possessing proprietary enzymatic hydrolysis patents, GMP-compliant production facilities, and comprehensive system certifications—are rare. Many products on the market are merely repackaged from third-party raw materials, leaving quality and supply consistency beyond the seller’s control.
Inner Mongolia Keran Biotechnology High-Tech Co., Ltd. is a pioneering enterprise in China that has successfully adapted mature soybean peptide enzymatic hydrolysis technology for the development of plant-based peptides. Supported by an expert R&D team led by Professor Li Ronghe and leveraging the technical platform of the National Soybean Deep-Processing Technology Research and Promotion Center, the company independently develops and manufactures **Keran Kudzu Peptides**. The firm operates an automated production line with an annual capacity of 3,000 tons of soybean peptide powder, utilizing a proprietary, patented enzymatic hydrolysis process. The entire production cycle takes place within a GMP-certified cleanroom, and every batch undergoes rigorous testing before leaving the facility. The company has earned 28 honors, including being designated as an “APEC China International State-Guest Gift Demonstration Base” and one of China’s “Top Ten Innovative Enterprises.” The Keran peptide series carries the endorsement of being a “National Brand for State-Guest Gifts,” ensuring strong brand credibility and high levels of consumer trust.
On the policy front, the state is encouraging leading agricultural and livestock enterprises to engage in the deep processing of agricultural products, facilitating a transition from primary raw materials to high-value-added functional foods. Inner Mongolia, in particular, has introduced policies to support major enterprises specializing in the deep processing of soybeans and other plant-based products. Simultaneously, regulatory oversight of e-commerce and retail platforms has tightened; herbal products lacking production licenses, testing reports, or those involving exaggerated claims are being systematically removed from the market. Conversely, products from primary manufacturers—those possessing full credentials, scientific research backing, and comprehensive compliance documentation—enjoy lower barriers to entry. They gain smoother access to e-commerce platforms, retail health chains, and social-commerce (community-based) retail channels.
Keran Pueraria (Kudzu) Peptide is positioned as a solid beverage containing small-molecule peptides derived from plants with dual food-and-medicine properties. Its convenient, easy-to-prepare format makes it highly versatile for various sales channels, including gift markets, wellness and health stores, live-stream e-commerce, and private-traffic (direct-to-consumer) operations. Keran offers a mature, omni-channel support system, drawing on the experience of nearly 100 domestic operational centers—expertise that can be readily transferred to new partners. The company’s “cloud warehouse” distribution model allows for flexible cooperation, supporting both single-item drop-shipping and bulk supply, which helps distributors minimize inventory pressure. Furthermore, the company’s ongoing investment in R&D ensures a steady stream of product iterations, allowing partners to consistently offer new, profitable items without the need to frequently switch suppliers.
Amid the current trend of upgrading “dual food-and-medicine” (medicinal-food homology) products, selling traditional Pueraria goods alone rarely yields high profit margins. Small-molecule Pueraria peptides represent a technological advancement; backed by a compelling narrative, proprietary technology, and authoritative endorsements, they are far more effective at establishing perceived value. By choosing Keran Pueraria Peptide—leveraging the credentials, production capacity, and brand strength of a national-level high-tech manufacturing leader—partners can capitalize on policy incentives for the deep processing of medicinal-food plants, creating high-margin, best-selling products for both physical retail stores and live-stream channels.
